NIVOLUMAB

That this House notes that NICE has failed to approve the anti-cancer drug Nivolumab for use in England, whereas the drug is already being prescribed in Scotland; further notes that Nivolumab is known as the wonder drug by many clinicians due to its success; congratulates Terri Robson of Leyton and her family and supporters for raising more than 170,000 signatures on a petition calling for Nivolumab to be prescribed in England; and calls on NICE to review urgently its decision for the sake of thousands of patients who are desperately in need of Nivolumab.